Lundbeck
HLUN-B.CO
#2621
Rank
S$8.44 B
Marketcap
S$8.90
Share price
0.55%
Change (1 day)
11.35%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): S$0.80

According to Lundbeck's latest financial reports the company's current EPS (TTM) is S$0.79. In 2024 the company made an earnings per share (EPS) of S$0.57 an increase over its 2023 EPS that were of S$0.44.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$0.8038.96%
2024S$0.5729.29%
2023S$0.4423.09%
2022S$0.3637.26%
2021S$0.26-84.61%
2020S$1.70-24.61%
2019S$2.26-42.06%
2018S$3.9040.7%
2017S$2.77146.26%
2016S$1.13-120.48%
2015S-$5.493231.32%
2014S-$0.16-115.78%
2013S$1.04-23.36%
2012S$1.36-48.01%
2011S$2.62-9.68%
2010S$2.9013.72%
2009S$2.5524.32%
2008S$2.05-6.05%
2007S$2.1981.77%
2006S$1.20-16.76%
2005S$1.44-17.58%
2004S$1.75